Acetylsulfanilamide

Acetylsulfanilamide

SCHEMBL8043497

CC(=O)Nc1ccc(S(N)(=O)=O)cc1.[KH]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA1 P00915 14/20 0.96
CA2 P00918 14/20 0.96
CA12 O43570 9/20 0.96
CA9 Q16790 9/20 0.96
IDO1 P14902 1/20 0.73
KMT2A Q03164 2/20 0.69
PLK1 P53350 1/20 0.68
CA7 P43166 2/20 0.67
CA4 P22748 1/20 0.67
PTPN7 P35236 1/20 0.64
PKM P14618 1/20 0.64
CYP2C19 P33261 1/20 0.64
CA14 Q9ULX7 1/20 0.64
MMP1 P03956 1/20 0.62
MMP2 P08253 1/20 0.62
MMP9 P14780 1/20 0.62
MMP8 P22894 1/20 0.62
MMP13 P45452 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetylsulfanilamide SCHEMBL359721 0.98 CA1 (1.00) CA1CA2CA12CA9IDO1
Acetylsulfanilamide SCHEMBL28550936 0.96 CA1 (0.96) CA1CA2CA12CA9IDO1
Acetylsulfanilamide SCHEMBL8190989 0.96 CA1 (0.96) CA1CA2CA12CA9IDO1
Acetylsulfanilamide SCHEMBL17360801 0.91 CA1 (0.86) CA1CA2CA12CA9IDO1
Acetylsulfanilamide SCHEMBL7429740 0.85 CA1 (0.76) CA1CA2CA12CA9IDO1
Sulfanilamide SCHEMBL11380883 0.84 CA1 (0.73) CA1CA2CA12CA9IDO1
SCHEMBL19379986 0.84 CA2 (0.73) CA1CA2CA12CA9KMT2A
SCHEMBL27291831 0.83 CA1 (0.73) CA1CA2CA12CA9KMT2A
SCHEMBL28226036 0.82 CA1 (0.67) CA1CA2CA12CA9KMT2A
Acedapsone SCHEMBL152710 0.82 PKM (0.85) CA1CA2CA12CA9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118203103-A Natural sweetness enhancer composition 伊比西(北京)植物药物技术有限公司 2024-06-18 CN disclosed
US-6030976-A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; CENTRAL NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE, PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, MEMORY DISORDERS, PARKINSON'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS AND HUNTINGTON'S DISEASE HOFFMAN-LA ROCHE INC. (US) 2000-02-29 US disclosed
US-5998665-A THERAPY FOR NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-12-07 US disclosed
US-5939451-A INDOL-4-YL-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-17 US disclosed
US-5932599-A 4-AMINO-N-(PYRIDINYL-4-YL)-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-03 US disclosed